Dyshidrotic Eczema (Pompholyx)

Spot diagnosis

• Intensely itchy
• Deep, clear vesicles
• Palms, sides of fingers, soles
• “Tapioca-like” appearance

Triggers

• Stress, sweating
• Nickel/cobalt
• Irritants, atopy

Diagnosis

• Clinical
• KOH only if tinea suspected

Management (OPD)

• High-potency topical steroid
  • Clobetasol 0.05% ointment BID × 7–14 days
• Emollients frequently
• Cold compress

Severe flare

• Prednisone 0.5–1 mg/kg/day PO × 5–7 days (short course)

Refractory

• Tacrolimus ointment
• Phototherapy
• Treat hyperhidrosis

Avoid

• Routine antibiotics
• Long-term systemic steroids

Key pearl

• Not sweat duct obstruction; eczema with high recurrence.

---

Dyshidrosis (Dyshidrotic eczema / Pompholyx) — doctor-level review and management

1) Definition and clinical phenotype

Dyshidrosis is a recurrent vesicular eczema affecting palms, lateral fingers, and soles, characterized by intensely pruritic, deep-seated vesicles that look like “tapioca pearls,” followed by desquamation, fissuring, and lichenification in chronic disease. It is best conceptualized as a subtype of chronic hand eczema (CHE) (often “recurrent vesicular hand eczema”). (arts.units.it)

---

2) Epidemiology and associations (what matters clinically)

• Hand eczema is common; dyshidrosis represents a recognizable vesicular phenotype within it. (arts.units.it)
• Strong associations:
  • Atopy (personal/family history of atopic dermatitis, allergic rhinitis, asthma)
  • Irritant exposure (wet work, detergents, solvents, frequent handwashing)
  • Allergic contact dermatitis (notably nickel/cobalt/chromate)
  • Hyperhidrosis and psychological stress as flare triggers (arts.units.it)

---

3) Pathophysiology (board-style, but clinically useful)

Think “eczema biology,” not sweat gland obstruction:

• Skin barrier dysfunction (reduced barrier lipids/filaggrin-related pathways in some patients) → increased irritant penetration and immune activation.
• Inflammation with spongiosis in epidermis → vesicle formation (the “tapioca” vesicles are essentially intraepidermal spongiotic vesicles).
• Triggers (irritants/allergens/stress/sweat) amplify immune signaling and barrier breakdown.The ESCD hand eczema guideline frames dyshidrosis within broader hand eczema evaluation (irritant + allergic + atopic contributors often overlap). (arts.units.it)

---

4) Clinical features and staging (how to “read” the rash)

Distribution

• Palms, lateral fingers; sometimes soles/toes.
• Dorsal hand involvement can occur but should raise concern for contact dermatitis pattern.

Morphology over time

1. Prodrome: itch/burning/tingling hours–days before eruption.
2. Acute vesicular phase: deep, tense vesicles; intense pruritus, sometimes pain.
3. Subacute: vesicles dry → scaling/peeling.
4. Chronic: fissures, thickening/lichenification; secondary infection risk increases.

Clues that suggest a “driver”

• Dominant palmar/side-of-finger vesicles with recurrent flares: classic dyshidrosis phenotype.
• Clear exposure pattern (new gloves, sanitizer, metal contact): consider allergic/irritant contact dermatitis coexisting.
• Unilateral involvement, annular scale, moccasin foot: consider tinea.

---

5) Differential diagnosis (and how to rule out efficiently)

1. Allergic contact dermatitis (ACD)
   • Often dorsal hands/wrists, sharp borders, exposure correlation.
   • Confirm with patch testing. (arts.units.it)
2. Irritant contact dermatitis (ICD)
   • “Wet work” history; burning > itch; chronic dryness/fissures.
   • Diagnosis is clinical; prevention is central. (arts.units.it)
3. Tinea manuum / pedis (dermatophyte)
   • Often unilateral hand (“two feet–one hand” pattern).
   • Do KOH and/or fungal culture. (arts.units.it)
4. Palmoplantar pustulosis / psoriasis
   • Sterile pustules, erythema, nail pitting/onycholysis; smoker association.
5. Scabies
   • Web spaces, burrows, nocturnal itch, household contacts.
6. Herpetic whitlow (important “don’t miss”)
   • Grouped vesicles, marked pain, possible systemic symptoms; consider if healthcare worker or HSV history.

---

6) Diagnostic work-up (what a dermatologist expects)

Dyshidrosis is usually clinical, but recurrent/severe disease benefits from structured evaluation.

Minimum evaluation in recurrent hand/foot vesicles

• Exposure history: wet work, soaps/sanitizers, gloves (rubber/latex), occupational chemicals, metals.
• Atopy history.
• Hyperhidrosis assessment.
• Fungal rule-out: KOH scraping if any scale/unilateral pattern/foot involvement. (arts.units.it)

When to order patch testing

• Chronic/recurrent hand eczema, severe disease, or suspicion of ACD (new products, occupational exposure, distribution suggests contact).ESCD/S2k guideline emphasizes patch testing as a key tool when ACD is possible. (arts.units.it)

Severity documentation (useful for follow-up and referrals)

• HECSI (Hand Eczema Severity Index) or a simpler “photographic + functional impairment” documentation is often used in studies and specialty care. (Dermatology Times)

---

7) Management (stepwise, practical, guideline-aligned)

A) Setting: OPD vs IPD

• Most patients: OPD (even severe flares).
• Consider IPD only if: extensive secondary infection/cellulitis requiring IV antibiotics, severe functional impairment with inability to care for self, or diagnostic uncertainty with systemic illness.

(Hand eczema guidelines are outpatient-focused; escalation is typically via specialty care rather than admission.) (arts.units.it)

B) Core principle: treat three targets every time

1. Inflammation control (anti-inflammatory therapy)
2. Barrier repair (emollients + protection)
3. Trigger control (irritant reduction, sweat control, allergy identification) (arts.units.it)

C) Patient Problem List (typical for dyshidrosis)

1. Acute vesicular hand/foot eczema flare (dyshidrosis phenotype)
2. Skin barrier failure (xerosis, fissuring, pain)
3. Pruritus affecting sleep/function
4. Possible triggers: irritant exposure / hyperhidrosis / suspected contact allergy
5. Monitor for secondary infection

---

Problem 1: Dyshidrosis flare (vesicular hand/foot eczema)

Definitive treatment (first-line)

High-potency topical corticosteroid (palms/soles need higher potency; ointment penetrates better)

• Clobetasol propionate 0.05% (thin layer) BID topical for 7–14 daysor
• Betamethasone dipropionate 0.05% (thin layer) BID topical for 7–14 days

Key technique: apply after a short soak, then ointment, then consider short-term occlusion (cotton glove) for a few nights if very thick skin—avoid prolonged occlusion if maceration/infection risk.

This aligns with hand eczema guideline frameworks emphasizing topical corticosteroids as mainstay anti-inflammatory therapy. (arts.units.it)

Supportive treatment (during acute vesicular stage)

• Wet compresses (to dry vesicles and reduce itch):
  • Aluminum acetate (Burow solution) compress 10–15 min, 2–4×/day for several days(common dermatology practice; used as symptomatic control in vesicular hand eczema) (American Academy of Dermatology)
• If itch disrupts sleep:
  • Hydroxyzine (25 mg) 1×1 PO HS PRNor non-sedating daytime option: cetirizine (10 mg) 1×1 PO daily.

Escalation for severe flare (short course)

• Prednisone 0.5 mg/kg/day PO for 5–7 days, then stop or taper if longer course is used.Use only for acute rescue; relapse can occur if triggers not controlled.

Guidelines generally reserve systemic steroids for short-term rescue rather than maintenance in chronic hand eczema. (arts.units.it)

Why not antibiotics routinely

Antibiotics are not indicated unless there is evidence of infection (oozing pus, honey crusting, increasing erythema/warmth, lymphangitis, fever). This is consistent with rational management of eczema and chronic hand eczema guidance emphasizing targeted therapy. (arts.units.it)

---

Problem 2: Barrier failure (dryness, scaling, fissures)

Definitive treatment (barrier repair)

• Petrolatum-based ointment or fragrance-free thick emollient at least 4–6×/day, always after handwashing.
• Night regimen: emollient + cotton gloves.

Supportive / protective measures (reduce irritant load)

• Replace soap-and-water with alcohol-based hand rub when hands are not visibly soiled (less irritating than repeated soap-and-water in many cases).
• “Glove protocol”:
  • Wet work: nitrile/vinyl gloves
  • Always use cotton liner and limit continuous wear; remove when sweating starts
• Avoid hot water, harsh detergents, fragranced products.

Hand eczema guidelines emphasize emollients and irritant avoidance as foundational therapy. (arts.units.it)

---

Problem 3: Pruritus and pain (functional impairment)

Definitive treatment

• Control inflammation (topical steroid is the pruritus treatment).

Supportive treatment

• Sedating antihistamine at night if sleep is impaired (as above).
• For fissure pain: thick ointment + occlusion; consider cyanoacrylate skin protectant for single fissures (clinical practice).

---

Problem 4: Trigger control (hyperhidrosis, allergy, occupational factors)

1) Hyperhidrosis-related flares

• Aluminum chloride hexahydrate 20% apply nightly to palms/soles; reduce frequency as tolerated.
• Consider tap-water iontophoresis or botulinum toxin via dermatology for refractory cases (specialist-level). (Medscape)

2) Suspected allergic contact dermatitis contributor

• Arrange patch testing for recurrent/chronic disease, especially with occupational exposure or poor response to standard therapy. (arts.units.it)

3) Fungal trigger (id reaction)

• If tinea pedis is present, treat it; it can perpetuate hand eczema in some patients. Hand eczema guidelines include ruling out and addressing infection triggers. (arts.units.it)

---

8) Refractory disease (dermatology escalation path)

If inadequate control after appropriate potency topical therapy + trigger control, consider escalation consistent with CHE guidance.

Steroid-sparing topical maintenance

• Tacrolimus 0.1% ointment BID topical (often as maintenance or for frequent relapses). (arts.units.it)

Phototherapy

• Narrowband UVB or PUVA can be effective for chronic/refractory hand eczema. (arts.units.it)

Systemic options (specialist-driven; consider local availability)

• Alitretinoin 30 mg 1×1 PO daily for 12–24 weeks for severe chronic hand eczema refractory to topical steroids (commonly used in Europe/Canada; requires strict pregnancy prevention, lipid/LFT monitoring). (arts.units.it)
• Immunosuppressants (off-label in many settings): cyclosporine, methotrexate, azathioprine, mycophenolate—choice depends on phenotype, comorbidities, monitoring capacity. (arts.units.it)
• Dupilumab: evidence supports benefit in severe chronic hand eczema subtypes including recurrent vesicular hand eczema; dosing in trials typically 600 mg loading then 300 mg every 2 weeks. (OUP Academic)

---

9) Monitoring, complications, and safety checks

Monitor treatment response

• Symptom control (itch, pain)
• Function (hand use, work ability)
• Skin integrity (fissures)
• Frequency of relapses
• Consider severity scoring (HECSI) in recurrent disease or specialty referral. (Dermatology Times)

Watch for infection

• Increasing erythema, warmth, tenderness, purulence, fever.
• If suspected, culture if significant drainage; treat appropriately.

Steroid safety (topical)

• High potency on palms is appropriate but limit continuous use:
  • Typical burst 1–2 weeks, then taper frequency or switch to maintenance regimen.
• Avoid chronic daily superpotent use without breaks (atrophy risk is lower on palms but still relevant).

---

10) Follow-up plan (what to write in the chart)

• Follow up in 2–4 weeks after initiating high-potency topical steroid burst.
• If improved: step down to intermittent steroid (weekend therapy) or calcineurin inhibitor maintenance + strict barrier care.
• If not improved:
  1. confirm diagnosis (KOH, patch testing),
  2. reassess exposures and adherence,
  3. consider phototherapy/systemic therapy referral. (arts.units.it)

---

11) Red flags (when to escalate urgently)

• Severe pain with grouped vesicles suggesting herpes (herpetic whitlow)
• Rapidly spreading erythema, fever, systemic symptoms (cellulitis)
• Widespread blistering beyond typical distribution
• Immunosuppressed patient with worsening lesions